Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac

Q1 Nursing
S.R. de Mol van Otterloo , J.M. Westerhoff , T. Leer , R.H.A. Rutgers , L.T.C. Meijers , L.A. Daamen , M.P.W. Intven , H.M. Verkooijen
{"title":"Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac","authors":"S.R. de Mol van Otterloo ,&nbsp;J.M. Westerhoff ,&nbsp;T. Leer ,&nbsp;R.H.A. Rutgers ,&nbsp;L.T.C. Meijers ,&nbsp;L.A. Daamen ,&nbsp;M.P.W. Intven ,&nbsp;H.M. Verkooijen","doi":"10.1016/j.tipsro.2023.100224","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Purpose</h3><p>Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients’ pre-treatment expectations of MRgRT are met and reports patients’ on-table experience on a 1.5 T MR-Linac.</p></div><div><h3>Materials and methods</h3><p>All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient’ physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience.</p></div><div><h3>Results</h3><p>We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52–90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients’ expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced.</p></div><div><h3>Conclusion</h3><p>Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000240/pdfft?md5=b9079f66d3a5754664a706af43d1b2c8&pid=1-s2.0-S2405632423000240-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technical Innovations and Patient Support in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405632423000240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Purpose

Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients’ pre-treatment expectations of MRgRT are met and reports patients’ on-table experience on a 1.5 T MR-Linac.

Materials and methods

All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient’ physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience.

Results

We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52–90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients’ expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced.

Conclusion

Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected.

患者对使用 1.5T MR-Linac 进行磁共振引导放射治疗的期望和体验
背景和目的在线自适应磁共振引导放疗(MRgRT)是一种相对较新的放疗方式,使用磁共振Linac进行放疗。目前尚不清楚患者对这种治疗的期望以及这些期望是否得到满足。本研究评估了患者在治疗前对 MRgRT 的期望是否得到满足,并报告了患者在 1.5 T MR-Linac 上的治疗体验。材料和方法所有在 2020 年 11 月至 2021 年 4 月期间接受 MR-Linac 治疗的患者均符合纳入条件。在治疗前、治疗中和治疗后三个月,通过问卷调查了解患者的期望和体验。现场体验问卷包括患者的生理和心理应对情况。患者的预期副作用、参与日常和社会活动的情况、疾病结果和疾病相关症状与治疗后的体验进行了比较。 结果 我们纳入了 113 名患者,他们主要为男性(n = 100,89%),中位年龄为 69 岁(52-90 岁不等)。在台上体验方面,90% 的患者(强烈)同意在治疗过程中感到平静。分别有 6% 和 8% 的患者认为治疗姿势或床不舒服。28%的患者在治疗过程中感到刺痛。治疗后,79% 的患者达到了预期效果。大多数患者在副作用(75%)、参与日常活动(83%)和社交活动(86%)以及症状(78%)方面的体验(好于)预期水平。结论1.5 T MR-Linac 治疗的耐受性良好,符合患者的期望。尽管一些患者期望获得更高的疗效,而且在治疗过程中经常出现刺痛感,但大多数患者的体验与之前的预期相当或更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
48
审稿时长
67 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信